N-aralkyl piperidine derivatives as psychotropic drugs
申请人:THE DU PONT MERCK PHARMACEUTICAL COMPANY
公开号:EP0449186A2
公开(公告)日:1991-10-02
There are provided N-aralkyl piperidine derivatives (I) which are selective sigma receptor antagonists. These compounds and pharmaceutical compositions containing them are useful for treating physiological or drug induced psychosis or dyskinesia in a mammal.
NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF
申请人:Eisai Co., Ltd.
公开号:EP1484327A1
公开(公告)日:2004-12-08
Compounds represented by the following general formula:
[wherein X1, X2, X3 and X4 each independently represent a single bond, C1-6 alkylene, etc.; A2 represents optionally substituted phenyl, etc.; A1 represents an optionally substituted 5- to 7-membered heterocyclic group containing -C(=Q1)- (wherein Q1 represents oxygen, sulfur or =N-R11 (wherein R11 represents hydrogen or C1-6 alkyl)) and nitrogen, etc.; and Z1 represents piperidin-diyl, etc.],
salts thereof and hydrates of the foregoing.